Key result
SARS-CoV-2 spike proteins induce lipid droplet formation in PBMCs without increasing cytokine release.
Why the study?
It was unknown whether SARS-CoV-2 spike proteins induce lipid droplet formation in human PBMCs and pulmonary microvascular endothelial cells and the related inflammatory response.
Do SARS-CoV-2 spike proteins induce lipid droplet formation in human PBMCs and HPMECs?
Do SARS-CoV-2 spike proteins induce lipid droplet formation in human PBMCs and HPMECs?
SARS-CoV-2 spike proteins induce lipid droplet formation in human PBMCs independent of inflammatory activation, suggesting a direct metabolic effect on immune cells.
Intracellular lipid droplets (LDs) can accumulate in response to inflammation, metabolic stresses, and other physiological/pathological processes. Herein, we investigated whether spike proteins of SARS-CoV-2 induce LDs in human peripheral blood mononuclear cells (PBMCs) and in pulmonary microvascular endothelial cells (HPMECs). PBMCs or HPMECs were incubated alone or with endotoxin-free recombinant variants of trimeric spike glycoproteins (Alpha, Beta, Delta, and Omicron, 12 µg/mL). Afterward, cells were stained with Oil Red O for LDs, cytokine release was determined through ELISA, and the gene expression was analyzed through real-time PCR using TaqMan assays. Our data show that spikes induce LDs in PBMCs but not in HPMECs. In line with this, in PBMCs, spike proteins lower the expression of genes involving lipid metabolism and LD formation, such as SREBF1, HMGCS1, LDLR, and CD36. On the other hand, PBMCs exposed to spikes for 6 or 18 h did not increase in IL-1β, IL-6, IL-8, MCP-1, and TNFα release or expression as compared to non-treated controls. Thus, spike-induced LD formation in PBMCs seems to not be related to cell inflammatory activation. Further detailed studies are warranted to investigate in which specific immune cells spikes induce LDs, and what are the pathophysiological mechanisms and consequences of this induction in vivo.
No takes yet. Share an insight, caveat, or question.
Sivaraman et al. (2023) studied this question. SARS-CoV-2 spike proteins (Alpha, Beta, Delta, Omicron) vs. Non-treated controls was evaluated on Lipid droplet formation and cytokine release. SARS-CoV-2 spike proteins induced lipid droplet formation in human peripheral blood mononuclear cells but not in pulmonary microvascular endothelial cells, without increasing cytokine release.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: